Log In
BCIQ
Print this Print this
 

SPI-205

  Manage Alerts
Collapse Summary General Information
Company Spectrum Pharmaceuticals Inc.
DescriptionLipid suspension of leteprinim
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationNeuropathy
Indication DetailsTreat chemotherapy-induced neuropathy (CTIN)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today